warning icon

COVID-19 DEW Report, powered by Reformulary®Read more

@var craft \craft\web\twig\variables\CraftVariable Header

Drugmaker Eli Lilly stays confident in possible COVID-19 treatment after setback

The United States government has suspended a study of an antibody drug made by Eli Lilly, claiming evidence does not show it improves outcomes in hospitalized COVID-19 patients. The manufacturer is still continuing to explore the efficacy of the drug in patients with mild to moderate disease in order to prevent hospitalization and severe illness.

Published: October 27, 2020

CTV News

Read Article